Results

Total Results: 2,098 records

Showing results for "studies".

  1. effectivehealthcare.ahrq.gov/products/grant-manuscripts/clinical-trial-registrations-abstract
  2. effectivehealthcare.ahrq.gov/products/clinical-care/rapid-research
  3. effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-appendix-f.xlsx
    October 08, 2025 - Risk of bias assessment for cohort studies Author, Year Did the study attempt to enroll all (or a random
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
    July 01, 2012 - The value of this approach in the ambulatory setting has been demonstrated in several studies.
  5. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1512.pdf
    December 29, 2015 - However, the experts wanted to see additional clinical studies that compare the efficacy of secukinumab … However, the experts thought that more clinical studies are needed to determine the long-term efficacy … were concerned about the reported adverse events.15,18 Some experts also wanted to see more clinical studies … of patients with complete tophus resolution.28 The most common adverse events reported in the two studies … Novartis AIN457 (secukinumab) meets primary endpoint in two phase III studies in ankylosing spondylitis
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
    April 01, 2010 - The goal was to determine a common robust quality indicator set for future comparative studies and quality
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/glucocorticoid-injections_clinician.pdf
    June 01, 2016 - A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis: A Brief Summary of Findings for Clinicians A Randomized Trial of Epidural Glucocorticoid Injections for Spinal Stenosis: A Brief Summary of Findings for Clinicians KEY CLINICAL ISSUE What are the relative effectiveness and adverse effect…
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-prepub-final-research-table-rct.xlsx
    May 29, 2025 - RCT Author, year Is randomization adequate? Yes/No/Unclear Is allocation concealment adequate? Yes/No/Unclear Are groups similar at baseline? Yes/No/Unclear Is the outcome assessor (interviewer) masked? Yes/No/Unclear Is the data analyst masked? Yes/No/Unclear Are attrition and crossovers reported? Yes/No/Uncl…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    October 08, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
    July 01, 2010 - sulfonylurea.”3 This twice daily injectable drug is approved for use only in adults, pending pediatric studies
  11. effectivehealthcare.ahrq.gov/products/outcomes-nutrition/research
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-creating-efficiencies-extraction-data.pdf
    August 01, 2021 - bPertains to the studies where the data element was identified as reported in the study by the human … cPertains to the studies where the data element was correctly identified as reported in the study by … Sentence 1 Participants were randomly assigned to an experimental group or a comparison group (24 studies
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    October 08, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  14. effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
    January 01, 2012 - However, one clinical expert stated that double-blind studies are needed to compare MSC therapy to … cartilage regeneration, evaluated by magnetic resonance imaging, would need to be shown by these studies … janus kinase inhibitor, in the treatment of rheumatoid arthritis: open-label, long-term extension studies
  15. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
    January 01, 2012 - Reports from observational studies suggested that helminths might prevent or improve UC by inducing … common and that people with helminths have an altered immunologic response to antigens. 2 Preclinical studies … relief at initial followup. 25 POEM has been generally well tolerated according to reports from studies
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-276-ocd-appendix-g.xlsx
    January 01, 2022 - child and adolescent anxiety center at Mayo Clinic + community controls: participated in two previous studies … : We should discuss studies that enroll at least one clinical sample, e.g.
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
    February 01, 2011 - initial observations, algorithm 3, which is consistent with the definition of diabetes in many previous studies
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pharma-nonpharma-ptsd-2022-update-app-g1.xlsx
    January 01, 2022 - Risk of Bias 2 assessment of new included studies RoB Domain Bias Due to Randomization (Cochrane) or
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    October 08, 2025 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  20. effectivehealthcare.ahrq.gov/products/ptsd-pharm-non-pharm-treatment-update/protocol

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: